Corgenix Announces Initial Phase Completion of Clinical Trial of Rapid Test for Lassa Fever

News   Apr 23, 2013

 
Corgenix Announces Initial Phase Completion of Clinical Trial of Rapid Test for Lassa Fever
 
 
 

RELATED ARTICLES

Blood Test Rapidly Detects Signs of Pancreatic Cancer

News

The new test can rapidly screen a drop of blood for biomarkers of pancreatic cancer, and provide results in less than an hour.

READ MORE

Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing Sites

News

Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.

READ MORE

CBD Significantly Reduces Seizures in Patients with Severe Form of Epilepsy

News

Large-scale clinical trial finds cannabidiol can dramatically reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE